Gaurav Burman Acquires Minority Stake in Mental Healthtech Startup Mitsu
Besides, angel investors including Shivashish Chatterjee and Yuvaraja C Singh-cofounders of DMI Finance, Harpreet Singh Grover, former cofounder of CoCubes and present founder of Curious Parent also invested in the startup.
Gaurav Burman, the director of Dabur International, has acquired a 7.5% stake in Mumbai-based mental healthtech startup Mitsu, for an undisclosed amount.
As part of this investment, Burman has also assumed a position on the startup's board.
Mitsu, founded in 2023 by Amit Singh, offers a guided self-therapy app tailored to individuals dealing with anxiety and depression. The platform features an eight-week intensive program to equip users with skills for long-term emotional well-being.
In addition to Gaurav Burman's investment, Mitsu has also received investment from angel investors including Shivashish Chatterjee and Yuvaraja C Singh-cofounders of DMI Finance, and Harpreet Singh Grover, former cofounder of CoCubes and present founder of Curious Parent.
One of Mitsu's notable claims is that users dedicate 25-30 minutes per week to the app, with the average user logging in two to three times a week. Mitsu's unique approach to mental health support stands out from traditional in-person therapy. Users benefit from ongoing assistance through in-app chat with the platform's in-house therapists, ensuring swift and timely help without appointment scheduling delays.
Importantly, Mitsu's program is available at just one-third the cost of in-person therapy, greatly enhancing affordability and accessibility, particularly for students.
The platform's approach is rooted in evidence-based methods such as Cognitive Behavioral Therapy (CBT), mindfulness, and Acceptance and Commitment Therapy (ACT).
This development in the mental health sector aligns with a growing trend in the industry. Earlier this month, LISSUN, another mental health solutions startup, secured $1.3 million in funding to expand its large-scale mental health offerings.
Moreover, a recent study conducted by UnivDatos Market Insights indicates that the Indian mental healthcare industry is on track to grow at a CAGR of 15% from 2022 to 2028.
Gaurav Burman's investment in Mitsu reflects a broader trend of investments in innovative and people-centric solutions that are shaping the future of healthcare. This growth can be attributed to increased awareness and the country's diminishing societal veto surrounding mental health.
